Need professional-grade analysis? Visit stockanalysis.com
$382.67M
N/A
3,699
N/A
Price Chart
Risk-Adjusted Performance
Healius Ltd (HLS) Price Performance
Healius Ltd (HLS) trades on Australian Securities Exchange in AUD. The company is classified in the Healthcare sector under the Diagnostics & Research industry. The stock currently trades at AUD0.56, up 4.63% from the previous close.
Over the past year, HLS has traded between a low of AUD0.50 and a high of AUD1.17. The stock has lost 43.4% over this period. It is currently 51.7% below its 52-week high.
Healius Ltd has a market capitalization of $382.67M.
About Healius Ltd
Healius Limited provides medical laboratory and pathology services in Australia. The company provides services under the Laverty Pathology, Dorevitch Pathology, QML Pathology, Western Diagnostic Pathology, Genomic Diagnostic, Vetnostics Pathology, QML Pathology, TML Pathology, Abbott Pathology, IQ Pathology, Kossard, Gastrolab, and Agilex Biolabs brands. It operates medical laboratories and patient collection centers. The company was formerly known as Primary Health Care Limited and changed its name to Healius Limited in December 2018. Healius Limited was incorporated in 1994 and is based in Sydney, Australia.
Compare Healius Ltd
Side-by-side comparison against top Healthcare peers.
Company Info
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Exchange
- Australian Securities Exchange
- Currency
- AUD
- Country
- Australia
Financial Metrics
- Revenue (TTM)
- $1.37B
- EBITDA
- $41.20M
- Profit Margin
- -12.32%
- EPS (TTM)
- -0.76
- Book Value
- 0.77
Technical Indicators
- 52 Week High
- A$1.20
- 52 Week Low
- A$0.49
- 50 Day MA
- A$0.66
- 200 Day MA
- A$0.81
- Beta
- 0.38
Valuation
- Trailing P/E
- N/A
- Forward P/E
- 22.73
- Price/Sales
- 0.28
- Price/Book
- 0.67
- Enterprise Value
- $1.26B